@article{iaccarino2021blood,
 abstract = {Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a chronic, clinically heterogenous fibroinflammatory condition, characterised by an accumulation of IgG4 secreting plasma cells in affected tissues and associated with increased serum IgG4 concentrations. Despite a growing recognition of the disease among clinicians from different specialties worldwide, its indolent nature, lack of a single diagnostic test and ability to mimic other malignant, infective and inflammatory conditions, makes the diagnosis challenging. As treatment options evolve, biomarkers correlating with disease activity, pr...},
 author = {MD PhD Luca Iaccarino and MD PhD Rosaria Talarico and MD Emanuele Bozzalla-Cassione and MD Gerd R. Burmester and MD PhD Emma L. Culver and MD Andrea Doria and MD Mikael Ebbo and P. M. Hagen and PhDHyunSunJeon Md and M. Laar and M. Lanzillotta and MD Fernando Martinez-Valle and Priya Md and M. Monti and M. Nalli and MD Nicolas Schleinitz and M. Tincani and MD Emanuel Della-Torre and Prof Alexander and P. M. Hagen},
 doi = {10.55563/clinexprheumatol/qq9qup},
 journal = {Clinical and experimental rheumatology},
 pages = {

},
 title = {Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.},
 year = {2021}
}